Kindeva Drug Delivery has acquired Summit Biosciences Inc., an intranasal drug-delivery CDMO, adding a new drug-delivery platform and further expanding Kindeva’s capabilities across a wider range of complex drug-device combination products (pulmonary, injectable, transdermal, and nasal).   Summit’s 55,000-sq.-ft. cGMP facility in Lexington, KY adds to Kindeva’s global manufacturing footprint of nine development and manufacturing facilities across the U.S. and U.K. The facility is approved by t...